The present invention relates to new analogous com- pounds of strobilurines. More specifically, the present invention relates to new analogous compounds of strobi- lurines having a high acaricidal and insecticidal activ- ity and their use as acaricides and insecticides.

Analogous products of strobilurines with a fungi- cidal activity are described in patent applications EP 178826, EP 226917, EP 253213, EP 278595, EP 398692.

Analogous products of strobilurines with an acarici- dal and insecticidal activity are described in patent ap- plications EP 242081, EP 299694, EP 335519. In particu- lar, this latter document describes benzyl-phenyl ethers with an acaricidal and insecticidal activity character- ized by the presence of the methoxyacrylate group in po- sition 2 of the benzyl group and not more than two sub- stituents on the phenol ring.

The acaricidal/insecticidal activity of the com-

pounds described in the above documents, however, are moderate and cannot be used for practical purposes.

The applicant has now found that in the series of benzyl-phenyl ethers, whose molecular structure is repre- sented by general formula (I), a surprisingly improved acaricidal and insecticidal activity is obtained when a substituent R is present on the phenol ring, as specified below, and at least two of the other four positions are occupied by halogen atoms.

An object of the present invention therefore relates to compounds having general formula (I) (I) wherein: - a group selected from Xi, X2 and X3 represents an R group ; - X4 and Xs and two of the remaining X1, X2, X3 groups represent a hydrogen atom or a halogen atom, on the con- dition that at least two of said groups represent a halo- gen atom;

- R represents a Cl-Cl2 alkyl or haloalkyl group ; a Cl-Cl2 alkoxy or alkylthio group optionally substituted by: halogen atoms, cyano groups, Cl-C6 alkoxy groups option- ally halogenated, C2-Clo alkoxyalkoxy groups optionally halogenated, NH2 groups optionally substituted by Cl-C6 alkyl groups optionally halogenated, C3-Cl2 trialkyl silyl groups, aryloxy or heteroaryloxy groups, in turn option- ally substituted by halogen atoms, C1-C6 alkyl groups op- tionally halogenated, C1-C6 alkoxy groups optionally halogenated, nitro groups, cyano groups; a C2Cl2 alkeny- loxy or alkenylthio group optionally substituted by halo- gen atoms, cyano groups, aryl groups or heteroaryl groups, in turn optionally substituted by halogen atoms, Cl-C6 alkyl, halo-alkyl, alkoxy, halo-alkoxy groups, ni- tro groups, cyano groups; a C3-Cl2 alkynyloxy or alky- nylthio group optionally substituted by halogen atoms, Cl-C6 alkoxy or haloalkoxy groups, aryl or heteroaryl groups, in turn optionally substituted by halogen atoms, Cl-C6 alkyl, haloalkyl, alkoxy, halo-alkoxy groups, nitro groups, cyano groups; a linear or branched C3-Cl2 alkoxy- iminoalkylidenoxy or alkoxyiminoalkylidenthio group ; a C3-C8 cycloalkoxy or cycloalkylthio group optionally sub- stituted by halogen atoms, Cl-C6 alkyl, haloalkyl, alk- oxy, haloalkoxy groups; a C4-C12 cycloalkylalkoxy or cy- cloalkylalkylthio group optionally substituted by halogen

atoms, Cl-C6 alkyl, haloalkyl, alkoxy, haloalkoxy groups ; a heterocyclyloxy, heterocyclylthio, heterocyclyl- (Cl- C6) alkoxy or hetero-cyclyl-(Cl-C6) alkylthio group, option- ally substituted by halogen atoms, (Cl-C6) alkyl, haloal- kyl, alkoxy, halo-alkoxy groups; an aryloxy, arylthio, heteroaryloxy, heteroarylthio, aryl- (Ci-Ce) alkoxy, aryl- (Cl-C6) alkylthio, heteroaryl- (Cl-C6) alkoxy or heteroaryl- (Cl-C6) alkylthio group optionally substituted by halogen atoms, Cl-C6 alkyl groups optionally halogenated, Cl-C6 alkoxy groups optionally halogenated, nitro groups, cyano groups ; - A, the same or different when n is greater than or equal to 2, represents a halogen atom or a Cl-C4 alkyl, haloalkyl, alkoxy, haloalkoxy group ; - Y represents an OCH3 group, an NHCH3 group, an NH2 group; - Z represents a CH group or a nitrogen atom N; - n is an integer ranging from 0 to 4.

Preferred compounds having general formula (I) are those wherein X3 represents an R group according to the meanings defined above, X2 and X4 represent a halogen atom, Xi and X5 represent a hydrogen atom and n is equal to 0.

In the meanings defined above, halogen atom refers to a fluorine, chlorine, bromine or iodine atom.

Alkyl group refers to a linear or branched group, such as, for example: a methyl, ethyl, iso-propyl, n- propyl, tert-butyl, iso-butyl, n-butyl, n-pentyl, 2, 2- dimethylpropyl, n-decyl group.

Haloalkyl group refers to a linear or branched group such as, for example: a trifluoromethyl, trichloromethyl, 2,2, 2-trifluoroethyl, 3,3, 3-trifluoropropyl, 2,2, 2- trifluoro-1-methylethyl group.

Alkoxy or alkylthio group optionally substituted re- fers to a linear or branched group such as, for example: a methoxy or methylthio group, a difluoromethoxy or di- fluormethylthio group, a trifluoromethoxy or trifluo- romethylthio group, an ethoxy or ethylthio group, a 2,2, 2-trifluoroethoxy or 2,2, 2-trifluoroethylthio group, a 2-fluoroethoxy or 2-fluoroethylthio group, a 1, 1,2, 2- tetrafluoroethoxy or 1,1, 2, 2-tetrafluoroethylthio group, a 1, 2-dichloro-1, 2-difluoroethoxy or 1, 2-dichloro-1, 2- difluoroethylthio group, an n-propoxy or n-propylthio group, an iso-propoxy or iso-propylthio group, a 3- chloropropoxy or 3-chloropropylthio group, a 3,3, 3- trifluoropropoxy or 3,3, 3-trifluoropropylthio group, a 1, 1, 2,3, 3,3-hexafluoropropoxy or 1,1, 2,3, 3,3- hexafluoropropylthio group, an n-butoxy or n-butylthio group, an iso-butoxy or iso-butylthio group, a tert- butoxy or tert-butylthio group, an n-pentoxy or n-

pentylthio group, a 3-methylbutoxy or 3-methylbutylthio group, a 3,3-dimethylbutoxy or 3,3-dimethylbutylthio, an n-hexyloxy or n-hexylthio group, an n-decyloxy or n- decylthio group, a methoxymethoxy or methoxymethylthio group, an ethoxymethoxy or ethoxymethylthio group, a 2- methoxyethoxy or 2-methoxyethylthio group, a 2- ethoxyethoxy or 2-ethoxyethylthio group, a 2- ethoxypropoxy or 2-ethoxypropylthio group, a 3- methoxyprop-2-yloxy or 3-methoxyprop-2-ylthio group, a 3- ethoxypropoxy or 3-ethoxypropylthio group, a 2- (2- chloroethoxy) ethoxy or 2- (2-chloroethoxy) ethyltio group, a 2- (2-fluoroethoxy) ethoxy or 2- (2-fluoroethoxy) ethyltio group, a 1, 1, 2-trifluoro-2-trifluoromethoxyethoxy or 1, 1, 2-trifluoro-2-trifluoromethoxyethylthio group, a 2- (1, 1, 2,2-tetrafluoroethoxy) ethoxy or 2- (1, 1,2, 2- tetrafluoroethoxy) ethylthio group, a 2- (2-methoxy- ethoxy) ethoxy or 2- (2-methoxyethoxy) ethylthio group, a 2- (2-ethoxyethoxy) ethoxy or 2- (2-ethoxyethoxy) ethylthio group, a cyanomethoxy or cyanomethylthio group, a 2- cyanoethoxy or 2-cyanoethylthio group, a 2-aminoethoxy or 2-aminoethylthio group, a 3-aminopropoxy or 3- aminopropylthio group, a 2-(N, N-dimethylamino) ethoxy or 2- (N, N-dimethylamino) ethylthio group, a 2- (N, N-diethyl- amino) ethoxy or 2- (N, N-diethylamino) ethylthio group, a 3- (N, N-dimethylamino) propoxy or 3- (N, N-dimethylamino) -

propylthio group, a 2- (N, N-diethylamino) propoxy or 2- (N, N-diethylamino) propylthio group, a 2- (N-ethylamino)- ethoxy or 2- (N-ethylamino) ethylthio group, a trimethylsi- lylmethoxy or trimethylsilylmethylthio group, a 2- (4- chlorophenoxy) ethoxy or 2- (4-chlorophenoxy)-ethylthio group, a 2- (4-methoxyphenoxy) ethoxy or 2- (4- methoxyphenoxy) ethylthio group, a 2- (4-trifluoro- methylphenoxy) ethoxy or 2- (4-trifluoromethylphenoxy)- ethylthio group, a 2- (5-trifluoromethyl-2-pyridyloxy)- ethoxy or 2- (5-trifluoromethyl-2-pyridyloxy) ethylthio group, a 3- (5-trifluoromehtyl-2-pyridyloxy) propoxy or 3- (5-trifluoromethyl-2-pyridyloxy) propylthio group.

An alkenyloxy or alkenylthio group optionally sub- stituted, refers to a linear or branched group such as, for example: a 2-propenyloxy or 2-propenylthio group, a 3-methyl-2-butenyloxy or 3-methyl-2-butenylthio group, a 3,3-dichloro-2-propenyloxy or 3,3-dichloro-2-propenylthio group, a 3-chloro-4,4, 4-trifluoro-2-butenyloxy or 3- chloro-4,4, 4-trifluoro-2-butenylthio group, a 3,4, 4,4- tetrafluoro-2-butenyloxy or 3,4, 4,4-tetrafluoro-2- butenylthio group, a 5,5-dichloro-4-pentenyloxy or 5,5- dichloro-4-pentenylthio group, a 3-cyano-2-propenyloxy or 3-cyano-2-propenylthio group, a 3-phenyl-2-propenyloxy or 3-phenyl-2-propenylthio group, a 3- (4-chlorophenyl)-2- propenyloxy or 3- (4-chlorophenyl)-2-propenylthio group.

An alkynyloxy or alkynylthio group optionally sub- stituted, refers to a linear or branched group such as, for example, a 2-propynyloxy or 2-propynylthio group, a 3-butynyloxy or 3-butynylthio group, a 3-butynyl-2-oxy or 3-butynyl-2-thio group, a 3-chloro-2-propynyloxy or 3- chloro-2-propynylthio group, a 4,4, 4-trifluoro-2- butynyloxy or 4,4, 4-trifluoro-2-butynylthio group, a 5- chloro-4-pentynyloxy or 5-chloro-4-pentynylthio group, a 4-methoxy-2-butynyloxy or 4-methoxy-2-butynylthio group, a 6-methoxy-4-butynyloxy or 6-methoxy-4-butynylthio group, a 3- (4-chlorophenyl)-2-propynyloxy or 3- (4-chloro- phenyl) -2-propynylthio group.

An alkoxyiminoalkylidenoxy or alkoxyimino- alkylidenthio group refers to a linear or branched group such as, for example: a 2-methoxyiminoethylidenoxy or 2- methoxyiminoethylidenthio group, a 2-methoxyimino- propylidenoxy or 2-methoxyiminopropylidenthio group.

Examples of cycloalkoxy or cycloalkylthio groups op- tionally substituted are: a cyclopentoxy or cyclopen- tylthio group, a cyclohexyloxy or cyclohexylthio group, a 2,2-difluorocyclohexyloxy or 2,2-difluoro-cyclohexylthio group, a 2,6-dimethylcyclohexyloxy or 2,6- dimethylcyclohexylthio group.

Examples of cycloalkylalkoxy or cycloalkylthio groups optionally substituted are: a cyclopropylmethoxy

or cyclopropylmethylthio group, a 1-cyclopropylethoxy or 1-cyclopropylethylthio group, a 2,2-dichlorocyclo- propylmethoxy or 2,2-dichlorocyclopropylmethylthio group, a 2, 2-dichloro-1-methylcyclopropylmethoxy or 2,2- dichloro-1-methylcyclopropylmethylthio group, a 2- methylcyclopropylmethoxy or 2-methylcyclopropyl- methylthio group, a 2,2-dimethylcyclopropylmethoxy or 2,2-dimethylcyclopropylmethylthio group, a cyclobutyl- methoxy or cyclobutylmethylthio group, a cyclohexyl- methoxy or cyclohexylmethylthio group.

A heterocyclyl group refers to a mono or polycyclic group with 3-14 members, saturated or unsaturated, op- tionally benzocondensed but not completely aromatic, con- sisting of carbon atoms and one or more heteroatoms, the same or different, to be selected from nitrogen, sulfur, oxygen.

Examples of heterocyclyloxy or heterocyclylthio groups optionally substituted, are therefore: a tetrahy- drofuranyloxy or tetrahydrofuranylthio group, a tetrahy- dropyranyloxy or tetrahydropyranylthio group, a tetrahy- drothiophenoxy or tetrahydrothiophenylthio group, a 1,3- dioxolanyloxy or 1,3-dioxolanylthio group, a 1,4- dioxanyloxy or 1,4-dioxanylthio group, a 3-piperidinyloxy or 3-piperidinylthio group, a 4-piperidinyloxy or 4- piperidinylthio group, a 1-methyl-3-piperidinyloxy or 1-

methyl-3-piperidinylthio group.

Examples of heterocyclyl- (Cl-C6) alkoxy or heterocy- clyl- (Cl-C6) alkylthio groups optionally substituted, are: a glycidyloxy or glycidylthio group, an oxethanylmethoxy or oxethanylmethylthio group, a tetrahydrofuranylmethoxy or tetrahydrofuranylmethylthio group, a tetrahydropy- ranylmethoxy or tetrahydropyranyl-methylthio group, a tetrahydrothiophenylmethoxy or tetrahydrothiophenylmeth- ylthio group, a 1, 3-dioxolanyl-methoxy or 1,3-dioxolanyl- methylthio group, a 1,4-dioxanylmethoxy or 1,4- dioxanylmethylthio group, a 1-piperidinylethoxy or 1- piperidinylethylthio group.

An aryl group refers to a mono-or poly-cyclic aro- matic carbocyclic group, such as phenyl and naphthyl.

Examples of aryloxy or arylthio groups optionally substituted, are therefore: a phenoxy or phenylthio group, a 4-trifluoromethylphenoxy or 4-trifluoro- methylphenylthio group, a 4-chlorophenoxy or 4- chlorophenylthio group, a 4-nitrophenoxy or 4- nitrophenylthio group, a naphthyloxy or naphthylthio group.

A hetero-aryl group refers to a mono or polycyclic aromatic group consisting of carbon atoms and one or more hetero-atoms, the same or different, to be selected from nitrogen, sulfur, oxygen; for example: pyridyl, thio-

phenyl, furanyl, pyrrolyl, pyrazolyl, pyrimidyl, tri- azolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, thiadiazolyl, triazinyl, tetrazinyl, benzoxazolyl.

Examples of hetero-aryloxy or hetero-arylthio groups optionally substituted are therefore: 2-pyridyloxy or 2- pyridylthio, 5-chloro-2-pyridyloxy or 5-chloro-2- pyridylthio, 5-trifluoromethyl-2-pyridyloxy or 5- trifluoromethyl-2-pyridylthio, 5-trifluoromethyl-1, 3,4- thiadiazolyloxy or 5-trifluoromethyl-1, 3,4-thiadiazol- ylthio.

Examples of aryl- (Cl-C6) alkoxy or aryl- (Cl- C6) alkylthio groups optionally substituted, are: a benzy- loxy or benzylthio group, a 4-chlorobenzyloxy or 4- chlorobenzylthio group, a 4-tert-butylbenzyloxy or 4- tert-butylbenzylthio group, a 1- (4-chlorophenyl) ethoxy or 1- (4-chlorophenyl) ethylthio group.

Examples of hetero-aryl- (Cl-C6) alkoxy or hetero- aryl- (Cl-C6) alkylthio groups optionally substituted, are: 2-furanylmethoxy or 2-furanylmethylthio, 5-nitro-2- furanylmethoxy or 5-nitro-2-furanylmethylthio, 2- thienylmethoxy or 2-thienylmethylthio, 3-pyridylmethoxy or 3-pyridylmethylthio, 6-chloro-3-pyridylmethoxy or 6- chloro-3-pyridylmethylthio.

Although the compounds having general formula (I) partially fall within the scope of the general formulae

of patent applications EP 178826, EP 226917, EP 252213, EP 278595 and EP 398692, they are not specifically illus- trated therein and are consequently new.

Compounds having formula (I) which are interesting for their biological activity are those described in Ex- amples 1-4 provided further on.

A further object of the present invention relates to the process for the preparation of the compounds having general formula (I).

The compounds having general formula (I) can be ob- tained by the condensation of a compound having general formula (II) with a phenol having general formula (III), according to reaction scheme 1:

(II) (III) in said formulae, X1/X2, X3, X4, X5, A, Y, Z and n have the meanings defined above, L represents a leaving group such as a chlorine atom, a bromine atom or a RLS03-group wherein RL represents a Cl-C6 alkyl or haloalkyl, or a

phenyl optionally substituted.

The reaction can be conveniently carried out in an inert organic solvent, at a temperature ranging from 0°C to the boiling point of the reaction mixture, optionally in the presence of an inorganic or organic base.

Preferred solvents for the reaction are alcohols (methanol, ethanol, propanol, methoxyethanol, etc.), ethers (ethyl ether, isopropyl ether, tetrahydrofuran, dioxane, dimethoxyethane, etc. ), esters (ethyl acetate,<BR> etc. ), ketones (acetone, methylethylketone, etc. ), chlo- rinated hydrocarbons (methylene chloride, dichloroethane, chloroform, carbon tetrachloride, etc. ), aromatic hydro-<BR> carbons (benzene, toluene, xylene, etc. ), aliphatic hy-<BR> drocarbons (hexane, heptane, cyclohexane, etc. ), aprotic dipolar solvents (N, N-dimethylformamide, dimethylsulfox- ide, sulfolane, etc.).

Preferred inorganic bases are: hydrides, hydroxides, carbonates of alkaline or alkaline-earth metals (sodium, potassium, calcium, etc.).

Preferred organic bases are: pyridine, dimethylami- nopyridine, aliphatic amines (diethylamine, triethyla- mine, etc. ), cyclic amines (morpholine, piperidine, di-<BR> azabicycloundecene, etc. ), alcoholates of alkaline metals (sodium methylate, potassium t-butylate, etc.).

The intermediates having general formula (II) are

known compounds.

The phenols of general formula (III), when not known in themselves, can be prepared according to methods known in organic chemical practice.

The compounds having general formula (I) wherein Y represents NH2 or NHCH3 can be alternatively prepared by reaction of the corresponding methyl esther [Y = OCH3 in <BR> <BR> general formula (I) ] with ammonia (NH3), or with methyl- amine (CH3NH2).

The reaction can be conveniently carried out in an inert organic solvent, at a temperature ranging from 0°C to the boiling point of the reaction mixture.

Preferred solvents for carrying out the reaction are alcohols (methanol, ethanol, propanol, methoxyethanol, <BR> <BR> etc. ), ethers (ethyl ether, isopropyl ether, tetrahydro-<BR> furan, dioxane, dimethoxyethane, etc. ), ketones (acetone,<BR> methylethylketone, etc. ), chlorinated hydrocarbons (meth- ylene chloride, dichloroethane, chloroform, carbon tetra- <BR> <BR> chloride, etc. ), aromatic hydrocarbons (benzene, toluene,<BR> xylene, etc. ), aliphatic hydrocarbons (hexane, heptane,<BR> cyclohexane, etc. ), aprotic dipolar solvents (N, N-<BR> dimethylformamide, dimethylsulfoxide, sulfolane, etc. ) or mixtures of these in any ratio.

The compounds having general formula (I) have an geometric isomerism on the C=Z double bond; the use of

the compounds having formula (I) as isomeric mixtures in any proportion, as also the production and use of the single E or Z isomers are included in the scope of the present invention. For the purposes of a biological ac- tivity E isomers of the compounds of formula (I) are pre- ferred.

The compounds having general formula (I) have a high acaricidal and insecticidal activity which is exerted with respect to the adults, larvae and eggs of mites and insects which are harmful in the agrarian, civil and zoo- technical field.

A further object of the present invention therefore relates to the use of the compounds having general for- mula (I) as acaricides and/or insecticides and/or fungi- cides, both in agriculture and other fields. In particu- lar, the use of E isomers of the compounds having formula (I) are preferred.

The use of the compounds having formula (I) wherein X3 represents an R group according to the meanings de- fined above, X2 and X4 represent a halogen atom, Xi and X5 represent a hydrogen atom and n is equal to 0, is pre- ferred.

Particularly preferred is the use of compounds hav- ing formula (I) selected from: - methyl (E)-2- [2- (4-cyclopropylmethoxy-3, 5-dichlorophen-

oxymethyl) phenyl]-3-methoxyacrylate ; - methyl (E)-2- [2- (4-cyclopropylmethoxy-3, 5-dichlorophen- oxymethyl) phenyl] -2-methoxyiminoacetate ; (E)-2- [2- (4-cyclopropylmethoxy-3, 5-dichlorophenoxy- methyl) phenyl]-N-methyl-2-methoxyiminoacetamide ; methyl (E)-2- {2- [4- (2, 2-dichlorocyclopropyl) methoxy- 3, 5-dichlorophenoxymethyl] phenyl}-3-methoxyacrylate ; - methyl (E)-2- {2- [4- (2, 2-dichlorocyclopropyl) methoxy- 3, 5-dichlorophenoxymethyl] phenyl}-2-methoxyiminoacetate ; - (E)-2- {2- [4- (2, 2-dichlorocyclopropyl) methoxy-3,5-di- chlorophenoxymethyl] phenyl}-N-methyl-2-methoxyiminOacet- amide; - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate ; - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate ; - (E)-2- {2- [3, 5-dichloro-4- (3, 3-dichloroprop-2-enyloxy)- phenoxymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide ; methyl (E)-2- {2- [3, 5-dichloro-4- (3-chloro-4, 4, 4- trifluorobut-2-enyloxy) phenoxymethyl] phenyl}-3-methoxy- acrylate; - methyl (E)-2- {2- [3, 5-dichloro-4- (3-chloro-4, 4,4-tri- fluorobut-2-enyloxy) phenoxymethyl] phenyl}-2-methOxyimi- noacetate; - (E)-2- {2- [3, 5-dichloro-4- (3-chloro-4, 4,4-tri-fluorobut-

2-enyloxy) phenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide; - methyl (E)-2- [2- (4-cyclobutylmethoxy-3, 5-dichloro- phenoxymethyl) phenyl]-3-methoxyacrylate ; - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dimethylbutoxy) phenoxymethyl] phenyl}-3-methoxyacrylate ; - methyl (E)-2- {2- [3, 5-dichloro-4- (3-methylbutoxy) phe- noxymethyl] phenyl}-3-methoxyacrylate ; - methyl (E)-2- [2- (4-cyclohexylmethoxy-3, 5-dichloro- phenoxymethyl] phenyl}-3-methoxyacrylate ; methyl (E)-2- {2- [3, 5-dichloro-4- (2, 4-dichloro- benzyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate ; methyl (E)-2- (2- [3, 5-dichloro-4- (4-chloro- benzyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate.

In particular, the compounds having general formula (I) are active against important species of tetranychidae (Tetranychus urticae, Tetranychus telarius, Tetranychus cinnabarinus, Eotetranychus carpini, Panonychus ulmi, Panonychus citri, etc. ), eriophyidae (Phytoptus avel-<BR> lanae, Eriophyes vitis, Eriophyes piri, etc. ) tarsonemi-<BR> dae (Steneotarsonemus pallidus, etc. ), hemiptera (Macro-<BR> siphum euphorbiae, Aphis fabae, Myzus persicae, etc. ),<BR> lepidoptera (Spodoptera spp. , Heliothis spp., Chilo spp. ,<BR> Carpocapsa pomonella, etc. ), coleoptera (Leptinotarsa de- cemlineata, Phaedon cochleariae, etc.), diptera (Aedes

spp. , Culex spp. , Musca spp. , etc.).

The compounds having general formula (I) also have a good fungicidal activity of both a preventive and cura- tive nature: examples of phytopathogen fungi which can be controlled with the compounds of the invention are: Hel- minthosporium spp. , Erysiphe spp. , Puccinia spp., Plasmo-<BR> para viticola, Pythium spp. , Phytophthora spp. , Rhyncho-<BR> sporium spp. , Septoria spp. , Sphaerotheca fuliginea, Po- dosphaera leucotricha, Pyricularia oryzae, Uncinula neca- tor, Venturia spp., Botrytis cinerea, Fusarium spp., Al- ternaria spp. , Cercospora spp.

At the same time, the compounds having general for- mula (I) have a low toxicity with respect to many useful insects and mites, with respect to mammals, fish, birds, and have no phytotoxicity.

Thanks to their positive characteristics, they can be advantageously used in defending not only crops of agrarian and horticultural interest, but also domestic and breeding animals, as well as environments frequented by human beings, from harmful mites, insects and fungi.

The quantity of compound to be applied to obtain the desired effect can vary in relation to various factors such as, for example, the compound used, the crop to be preserved, the type of harmful organism, the degree of infestation, the climatic conditions, the method of ap-

plication, the formulation adopted.

Doses of compound ranging from 10 g to 5 kg per hec- tare generally provide a sufficient control.

A further object of the present invention also re- lates to a method for controlling mites and/or insects and/or phytopathogenic fungi in crops of agrarian and horticultural interest and/or on domestic and breeding animals and/or in environments frequented by human be- ings, by the application of the compounds having general formula (I). In particular, the quantity of compound to be applied varies from 10 g to 5 kg per hectare.

For practical use in agriculture, it is often useful to use compositions containing one or more compounds hav- ing general formula (I).

A further object of the present invention therefore relates to acaricidal and/or insecticidal and/or fungi- cidal compositions containing one or more compounds hav- ing general formula (I) as active principle.

Compositions can be used in the form of dry powders, wettable powders, emulsifiable concentrates, micro- emulsions, pastes, granulates, solutions, suspensions, etc.: the selection of the type of composition depends on the specific use.

The compositions are prepared in the known way, for example by diluting or dissolving the active substance

with a solvent medium and/or a solid diluent, optionally in the presence of surface-active agents.

Solid diluents, or carriers which can be used are, for example: silica, kaolin, bentonite, talc, diatomite, dolomite, calcium carbonate, magnesia, chalk, clays, syn- thetic silicates, attapulgite, seppiolite.

Liquid diluents which can be used are, for example, in addition to water, aromatic organic solvents (xylols or mixtures of alkylbenzols, chlorobenzene, etc. ), paraf- fins (petroleum fractions), alcohols (methanol, propanol, butanol, octanol, glycerin, etc. ), esters (ethyl acetate,<BR> isobutyl acetate, etc. ), ketones (cyclohexanone, acetone,<BR> acetophenone, isophorone, ethylamylketone, etc. ), amides (N, N-dimethylformamide, N-methylpyrrolidone, etc.).

Surface-active agents which can be used are salts of sodium, calcium, triethylamine or triethanolamine of al- kylsulfonates, alkylarylsulfonates, polyethoxylated al- kylphenols, polyethoxylated esters of sorbitol, lignin- sulfonates, etc.

The compositions can also contain special additives for particular purposes, for example adhesion agents such as Arabic gum, polyvinyl alcohol, polyvinyl-pyrrolidone, etc.

The concentration of active principle in the above compositions can vary within a wide range depending on

the active compound, the applications for which they are destined, the environmental conditions and the type of formulation adopted. In general the concentration of ac- tive principle ranges from 1 to 90%, preferably from 5 to 50%.

If required, it is possible to add to the composi- tions, other active principles compatible with the com- pounds having general formula (I), such as, for example, other acaricides/insecticides, fungicides, phyto- regulators, antibiotics, herbicides, fertilizers.

Examples of other acaricides/insecticides which can be added to the above compositions are: abamectin, acephate, acetamiprid, acetoprole, acrinathrin, acequino- cyl, alanycarb, aldicarb, allethrin, alpha-cypermethrin, amitraz, azadirachtin, azamethiphos, azinphos-ethyl, az- inphos-methyl, azocyclotin, bendiocarb, benfuracarb, ben- sultap, benzoximate, bifenazate, bifenthrin, bioalle- thrin, bioresmethrin, bistrifluron, (DBI-3204), bromopro- pylate, buprofezin, butocarboxim, butoxycarboxim, cadusa- fos, carbofuran, carbosulfan, cartap, CGA 50439, chinome- thionat, chlordane, chlorethoxyfos, chlorfenapyr, chlor- fenvinphos, chlorfluazuron, chlormephos, chloropicrin, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clo- fentezine, clothianidin, coumaphos, cyanophos, cyclopro- thrin, cyfluthrin, cyhalothrin, cyhexatin, cypermethrin,

cyphenothrin, cyromazine, DDT, deltamethrin, demeton-S- methyl, diafenthiuron, diazinon, dichlorvos, dicofol, di- crotophos, dicyclanil, dienochlor, diflubenzuron, di- methoate, dimethylvinphos, dinobuton, dinocap, dinotefu- ran (MTI-446), diofenolan, disulfoton, DNOC, indoxacarb, endosulfan, EPN, esfenvalerate, ethiofencarb, ethion, ethiprole, ethoprophos, etofenprox, etoxazole, etrimfos, famphur, fenazaquin, fenbutatin oxide, fenitrothion, fe- nobucarb, fenothiocarb, fenoxycarb, fenpropathrin, fenpy- roximate, fenthion, fenvalerate, fipronil, flucycloxuron, flucythrinate, flufenoxuron, flufenprox, flufenzin, flu- methrin, fluvalinate, fonofos, formetanate, formothion, furathiocarb, halfenprox, halofenozide, heptachlor, hep- tenophos, hexaflumuron, hexythiazox, hydroprene, IKA- 2000, IKI-220, imidacloprid, isazofos, isofenphos, iso- procarb, isoxathion, lindane, lufenuron, malathion, me- carbam, methacrifos, methamidophos, methidathion, methio- carb, methyl, methoprene, methoxychlor, methoxyfe- nozide, metolcarb, mevinphos, milbemectin, monocrotophos, naled, nicotine, nitenpyran, nithiazine, novaluron, omethoate, oxamyl, oxydemeton-methyl, parathion, per- methrin, petroleum oils, phenothrin, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimicarb, pirimiphos-ethyl, pirimiphos-methyl, profenofos, pro- paphos, propargite, propetamphos, propoxur, prothiofos,

protrifenbute, pymetrozine, pyraclofos, pyrethrins, pyridaben, pyridaphenthion, pyrimidifen, pyriproxyfen, quinalphos, rotenone, S-1812, silafluofen, spirodiclofen (BAJ2740), sulfluramid, sulfotep, sulprofos, tar oils, tebufenozide, tebufenpyrad, tebupirimfos, teflubenzuron, tefluthrin, temephos, terbufos, tetrachlorvinphos, tetra- difon, tetramethrin, thiacloprid, thiamethoxam, thiocy- clam, thiodicarb, thiofanox, thiometon, tolfenpyrad, tra- lomethrin, transfluthrin, triazamate, triazophos, tri- chlorfon, triflumuron, trimethacarb, vamidothion, spino- sad, vaniliprole, XMC, xylylcarb, ZXI 8901.

Some examples are provided for illustrative pur- poses but in no way limit the scope of the present inven- tion.

EXAMPLE 1 Preparation of methyl (E)-2- [2- (4-cyclopropylmethoxy- 3,5-dichlorophenoxymethyl) phenyl]-3-methoxyacrylate (com- pound Nr. 1).

A solution of 4-cyclopropylmethoxy-3,5-dichloro- phenol (1.54 g; 6.6 mmoles) in DMF (5 ml) is added drop- wise, at 0°C, to a suspension of sodium hydride (0.16 g; 6.6 mmoles) in N, N-dimethyl formamide (DMF; 5 ml). The mixture is kept under stirring at room temperature for 30 minutes and a solution of methyl (E)-2- (2-

bromomethylphenyl) -3-methoxyacrylate (1.9 g; 6.6 mmoles) in DMF (5 ml) is then added. The mixture is kept under stirring for 4 hours ; the mixture is diluted with water (40 ml) and an extraction is effected with ethyl acetate (3x25 ml). The organic phases are joined, washed with wa- ter (2x20 ml), dried with sodium sulfate, filtered and concentrated at reduced pressure. The raw product ob- tained is purified by means of silica gel chromatography, eluting with hexane/ethyl acetate 9: 1.1. 9 g of the de- sired product (thick oil) are obtained.

1H-NMR (CDC13) : 5 0.33 (2H, m), 0.61 (2H, m), 1.30 (lH, m), 3. 71 (3H, s), 3.78 (2H, d), 3.85 (3H, s), 4.90 (2H, s), 6.82 (2H, s), 7.10-7. 55 (4H, m), 7,61 (lH, s).

EXAMPLE 2 Preparation of methyl (E)-2- [2- (4-cyclopropylmethoxy- 3, 5-dichlorophenoxymethyl)-phenyl]-2-methoxyiminoacetate (compound Nr. 2).

A solution of 4-cyclopropylmethoxy-3,5-dichloro- phenol (1.54 g; 6.6 mmoles) in DMF (5 ml) is added drop- wise, at 0°C, to a suspension of sodium hydride (0.16 g; 6.6 mmoles) in DMF (5 ml). The mixture is kept under stirring at room temperature for 30 minutes, and a solu- tion of methyl (E)-2- (2-bromomethylphenyl)-3- methoxyiminoacetate (1.9 g; 6.6 mmoles) in DMF (5 ml) is then added. The mixture is kept under stirring for 4

hours ; the mixture is diluted with water (40 ml) and an extraction is effected with ethyl acetate (3x25 ml). The organic phases are joined, washed with water (2x20 ml), dried with sodium sulfate, filtered and concentrated at reduced pressure. The raw product obtained is purified by means of silica gel chromatography, eluting with hex- ane/ethyl acetate 9: 1.1. 7 g of the desired product (thick oil) are obtained.

H-NMR (CDCl3) : 8 0.33 (2H, m), 0.61 (2H, m), 1.30 (lH, m), 3.78 (2H, d), 3.85 (3H, s), 4.03 (3H, s), 4.90 (2H, s), 6.82 (2H, s), 7.10-7. 55 (4H, m).

EXAMPLE 3 Preparation of (E)-2- [2- (4-cyclopropylmethoxy-3, 5-di- chlorophenoxymethyl)-phenyl]-N-methyl-2-methoxyimino- acetamide (compound Nr. 3).

A 40% aqueous solution of methylamine (0.8 ml) is added to a solution of methyl (E)-2- [2- (4- cyclopropylmethoxy-3, 5-dichlorophenoxymethyl)-phenyl]-2- methoxyiminoacetate (compound nr. 2; 0.88g ; 2 mmoles) in DMF (2 ml) and methanol (4 ml). The mixture is kept under stirring for 2 hours at room temperature, diluted with water (40 ml) and an extraction is effected with ethyl acetate (3x25 ml). The organic phases are joined, washed with water (2x20 ml), dried with sodium sulfate and con- centrated at reduced pressure. 0.8 g of the product

(thick oil) are obtained, which do not require further purification.

1H-NMR (CDC13) : 8 0.33 (2H, m), 0.61 (2H, m), 1.30 (lH, m), 2.90 (3H, d), 3.78 (2H, d), 4.03 (3H, s), 4.90 (2H, s), 6.78 (lH, mb), 6.82 (2H, s), 7.10-7. 55 (4H, m).

EXAMPLE 4 Preparation of compounds Nr. 4-146.

Operating as described in examples 1-3, the follow- ing products were prepared and identified by means of 1H- NMR spectroscopy and GC-MS: - methyl (E)-2- [2- (4-cyclopentoxy-3, 5-dichlorophenoxy- methyl) phenyl]-3-methoxyacrylate (compound Nr. 4); - methyl (E)-2- [2- (4-cyclopentoxy-3, 5-dichlorophenoxy- methyl) phenyl]-2-methoxyiminoacetate (compound Nr. 5) ; <BR> <BR> (E)-2- [2- (4-cyclopentoxy-3, 5-dichlorophenoxymethyl) phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 6); - methyl (E)-2- [2- (4-cyclobutylmethoxy-3, 5-dichloro- phenoxymethyl) phenyl]-3-methoxyacrilate (compound Nr. 7); - methyl (E)-2- [2- (4-cyclobutylmethoxy-3, 5-dichloro- phenoxymethyl) phenyl]-2-methoxyiminoacetate (compound Nr. 8); (E)-2- [2- (4-cyclobutylmethoxy-3, 5-dichlorophenoxy- methyl) phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 9); - methyl (E)-2- [2- (4-cyclohexyloxy-3, 5-dichlorophe-

noxymethyl) phenyl]-3-methoxyacrylate (compound Nr. 10) ; - methyl (E)-2- [2- (4-cyclohexyloxy-3, 5-dichlorophe- noxymethyl) phenyl] -2-methoxyiminoacetate (compound Nr. lu) ; (E)-2- [2- (4-cyclohexyloxy-3, 5-dichlorophenoxymethyl) phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 12) ; - methyl (E)-2- [2- (4-cyclohexylmethoxy-3, 5-dichlorophe noxymethyl) phenyl]-3-methoxyacrylate, solid with m. p.

103°C ; 1H-NMR (CDCl3) : 8 1.22 (5H, m), 1.88 (6H, m), 3.73 (3H, s), 3.74 (2H, d), 3.82 (3H, s), 4.93 (2H, s), 6.84 (2H, s), 7.10- 7.55 (4H, m), 7.62 (lH, s). (compound Nr. 13) ; - methyl (E)-2- [2- (4-cyclohexylmethoxy-3, 5-dichlorophe noxymethyl) phenyl]-2-methoxyiminoacetate (compound Nr. 14) ; (E)-2- [2- (4-cyclohexylmethoxy-3, 5-dichlorophenoxy- methyl) phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 15) ; - methyl (E)-2- [2- (3, 5-dichloro-4-methoxyphenoxy- methyl) phenyl]-3-methoxyacrylate (compound Nr. 16) ; - methyl (E)-2- [2- (3, 5-dichloro-4-metoxyphenoxy- methyl) phenyl]-2-methoxyiminoacetate (compound Nr. 17) ; - (E)-2- [2- (3, 5-dichloro-4-methoxyphenoxymethyl) phenyl- N-methyl-2-methoxyiminoacetamide (compound Nr. 18) ; - methyl (E)-2- [2- (3, 5-dichloro-4-ethoxyphenoxymethyl) phenyl]-3-methoxyacrylate (compound Nr. 19) ;

methyl (E)-2- [2- (3, 5-dichloro-4-ethoxyphenoxymethyl) phenyl]-2-methoxyiminoacetate (compound Nr. 20); (E)-2- [2- (3, 5-dichloro-4-ethoxyphenoxymethyl) phenyl] -N-methyl-2-methoxyiminoacetamide (compound Nr. 21); - methyl (E)-2- [2- (3, 5-dichloro-4-isopropoxyphenoxy- methyl) phenyl]-3-methoxyacrylate (compound Nr. 22); - methyl (E)-2- [2- (3, 5-dichloro-4-isopropoxyphenoxyme- thyl) phenyl]-2-methoxyiminoacetate (compound Nr. 23); (E)-2- [2- (3, 5-dichloro-4-isopropoxyphenoxymethyl) - phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 24); - methyl (E)-2- [2- (3, 5-dichloro-4-isobutoxyphenoxy- methyl) phenyl]-3-methoxyacrylate (compound Nr. 25); - methyl (E)-2- [2- (3, 5-dichloro-4-isobutoxyphenoxyme- thyl) phenyl]-2-methoxyiminoacetate (compound Nr. 26); (E)-2- [2- (3, 5-dichloro-4-isobutoxyphenoxymethyl) - phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 27); - methyl (E)-2- {2- [3, 5-dichloro-4- (2, 2-dimethylpropo- xy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 28); - methyl (E)-2- {2- [3, 5-dichloro-4- (2, 2-dimethylpropo- xy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 29); (E)-2- (2- [3, 5-dichloro-4- (2, 2-dimethylpropoxy) phe- noxymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide (com- pound Nr. 30);

methyl (E)-2- {2- [3, 5-dichloro-4- (2, 2-dimethylethoxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 31); - methyl (E)-2- {2- [3, 5-dichloro-4- (2, 2-dimethylethoxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 32); - (E)-2- {2- [3, 5-dichloro-4- (2, 2-dimethylethoxy) pheno- xymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide (com- pound Nr. 33) ; <BR> <BR> - methyl (E)-2- {2- [3, 5-dichloro-4- (3-methylbutoxy)- phenoxymethyl] phenyl}-3-methoxyacrylate, m. p. 70°C ; H-NMR (CDC13) : 8 1. 0 (6H, d), 1.73 (2H, m), 1.94 (lH, m), 3.73 (3H, s), 3.82 (3H, s), 3.98 (2H, m), 4.93 (2H, s), 6.84 (2H, s), 7.10-7. 55 (4H, m), 7.62 (lH, s). (compound Nr. 34); <BR> <BR> - methyl (E)-2-2- [3, 5-dichloro-4- (3-methylbutoxy)- phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 35); - (E)-2- {2- [3, 5-dichloro-4- (3-methylbutoxy) phenoxy- methyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 36); - methyl (E)-2- [2- (3, 5-dichloro-4-hexyloxyphenoxy- methyl) phenyl]-3-methoxyacrylate (compound Nr. 37); <BR> <BR> - methyl (E)-2- [2- (3, 5-dichloro-4-hexyloxyphenoxyme- thyl) phenyl]-2-methoxyiminoacetate (compound Nr. 38); (E)-2- [2- (3, 5-dichloro-4-hexyloxyphenoxymethyl)<BR> phenyl] -N-methyl-2-methoxyiminoacetamide (compound Nr. 39);

methyl (E)-2- [2- (3, 5-dichloro-4-decyloxyphenoxy- methyl) phenyl]-3-methoxyacrylate (compound Nr. 40); - methyl (E)-2- [2- (3, 5-dichloro-4-decyloxyphenoxyme- thyl) phenyl] -2-methoxyiminoacetate (compound Nr. 41);<BR> (E)-2- [2- (3, 5-dichloro-4-decyloxyphenoxymethyl) - phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 42); - methyl (E)-2- [2- (3, 5-dichloro-4-n-propoxyphenoxy- methyl) phenyl]-3-methoxyacrylate (compound Nr. 43); - methyl (E)-2- [2- (3, 5-dichloro-4-n-propoxyphenoxyme- thyl) phenyl]-2-methoxyiminoacetate (compound Nr. 44); (E)-2- [2- (3, 5-dichloro-4-n-propoxyphenoxymethyl) - phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 45); - methyl (E)-2- (2- [3, 5-dichloro-4- (2-ethoxyethoxy)- phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 46); methyl (E)-2- {2- [3, 5-dichloro-4- (2-ethoxyethoxy)- phenoxymethyl] phenyl}-2-methoxyaminoacetate (compound Nr. 47); - (E)-2- {2- [3, 5-dichloro-4- (2-ethoxyethoxy) phenoxyme- thyl] phenyl}-2-methoxyaminoacetamide (compound Nr. 48); - methyl (E)-2- {2- [3, 5-dichloro-4- (2-methoxyethoxy)- phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 49); - methyl (E)-2- {2- [3, 5-dichloro-4- (2-methoxyethoxy)- phenoxymethyl] phenyl}-2-methoxyaminoacetate (compound Nr. 50); - (E)-2- {2- [3, 5-dichloro-4- (2-methoxyethoxy) phenoxyme-

thyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 51); methyl (E)-2- {2- [3, 5-dichloro-4- (2-ethoxymethoxy)- phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 52); - methyl (E)-2- {2- [3, 5-dichloro-4- (2-ethoxymethoxy)- phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 53); (E)-2- {2- [3, 5-dichloro-4- (2-ethoxymethoxy)-phenoxy- methyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 54); - methyl (E)-2- {2- [3, 5-dichloro-4- (2, 2,2-trifluoro- ethoxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 55); - methyl (E)-2- {2- [3, 5-dichloro-4- (2, 2,2-trifluoro- ethoxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 56); - (E)-2- {2- [3, 5-dichloro-4- (2, 2,2-trifluoroethoxy)- phenoxymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 57); - methyl (E)-2- [2- (3, 5-dichloro-4-trifluoromethoxy- phenoxymethyl) phenyl]-3-methoxyacrylate (compound Nr. 58); - methyl (E)-2- [2- (3, 5-dichloro-4-trifluoromethoxy- phenoxymethyl) phenyl]-2-methoxyiminoacetate (compound Nr. 59); (E)-2- [2- (3, 5-dichloro-4-trifluoromethoxyphenoxy-

methyl) phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 60); - methyl (E)-2- {2- [3, 5-dichloro-4- (1, 1,2, 2-tetrafluoro- ethoxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 61); - methyl (E)-2- {2- [3, 5-dichloro-4- (1, 1,2, 2-tetrafluoro- ethoxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 62); - (E)-2-2- [3, 5-dichloro-4- (1, 1,2, 2-tetrafluoro- ethoxy) phenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 63); - methyl (E)-2- {2- [3, 5-dichloro-4- (1, 1,2, 3,3, 3- hexafluoropropoxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 64); - methyl (E)-2- {2- [3, 5-dichloro-4- (1, 1,2, 3,3, 3- hexafluoropropoxy) phenoxymethyl] phenyl}-2-methoxyimino- acetate (compound Nr. 65); - (E)-2- {2- [3, 5-dichloro-4- (1, 1,2, 3,3, 3-hexafluoro- propoxy) phenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 66); - methyl (E)-2- {2- [3, 5-dichloro-4- (2-trifluoromethoxy- 1, 1, 2-trifluoroethoxy) phenoxymethyl] phenyl}-3-methoxy- acrylate (compound Nr. 67); - methyl (E)-2- (2- [3, 5-dichloro-4- (2-trifluoromethoxy- 1, 1, 2-trifluoroethoxy) phenoxymethyl] phenyl}-2-methoxy-

iminoacetate (compound Nr. 68); (E)-2- {2- [3, 5-dichloro-4- (2-trifluoromethoxy-l, l, 2- trifluoroethoxy) phenoxymethyl] phenyl}-N-methyl-2-methOxy- iminoacetamide (compound Nr. 69); - methyl (E)-2- {2- [3, 5-dichloro-4- (2- (2-ethoxyethoxy)- ethoxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 70); - methyl (E)-2- {2- [3, 5-dichloro-4- (2- (2-ethoxyethoxy)- ethoxy) phenoxymethyl] phenyl}-3-methoxyiminoacetate (com- pound Nr. 71); (E)-2- {2- [3, 5-dichloro-4- (2- (2-ethoxyethoxy) ethoxy)- phenoxymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 72); - methyl (E)-2- {2- [3, 5-dichloro-4- (4-trifluoromethyl- phenoxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 73); - methyl (E)-2- {2- [3, 5-dichloro-4- (4-trifluoromethyl- phenoxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 74); - (E)-2- {2- [3, 5-dichloro-4- (4-trifluoromethylphenoxy)-<BR> phenoxymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 75); - methyl (E)-2- {2- [3, 5-dichloro-4- (4-cyanophenoxy)- phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 76); - methyl (E)-2- {2- [3, 5-dichloro-4- (4-cyanophenoxy)-

phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 77); - (E)-2- {2- [3, 5-dichloro-4- (4-cyanophenoxy) phenoxy- methyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 78); - methyl (E)-2- {2- [3, 5-dichloro-4- (4-nitrophenoxy)- phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 79); methyl (E)-2- {2- [3, 5-dichloro-4- (4-nitrophenoxy)- phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 80); - (E)-2- {2- [3, 5-dichloro-4- (4-nitrophenoxy) phenoxy- methyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 81); - methyl (E)-2- [2- (3, 5-dichloro-4-benzyloxyphenoxy- methyl) phenyl]-3-methoxyacrylate (compound Nr. 82); methyl (E)-2- [2- (3, 5-dichloro-4-benzyloxyphenoxy- methyl) phenyl]-2-methoxyiminoacetate (compound Nr. 83); (E)-2- [2- (3, 5-dichloro-4-benzyloxyphenoxymethyl) - phenyl]-N-methyl-2-methoxyiminoacetamide (compound nr. 84); <BR> <BR> - methyl (E)-2- {2- [3, 5-dichloro-4- (4-methoxybenzyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 85); <BR> <BR> - methyl (E)-2- {2- [3, 5-dichloro-4- (4-methoxybenzyloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 86);

(E)-2- {2- [3, 5-dichloro-4- (4-methoxybenzyloxy)- phe- noxymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide (com- pound Nr. 87); - methyl (E)-2- {2- [3, 5-dichloro-4- (4-tert-butyl) ben- zyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 88); - methyl (E)-2- {2- [3, 5-dichloro-4- (4-tert-butyl) benzy- loxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 89); - (E)-2- {2- [3, 5-dichloro-4- (4-tert-butyl) benzyloxy) phenoxymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 90); - methyl (E)-2- {2- [3, 5-dichloro-4- (5-trifluoromethyl- pyrid-2-yloxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 91); <BR> <BR> - methyl (E)-2- {2- [3, 5-dichloro-4- (5-trifluoromethyl-<BR> pyrid-2-yloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 92); <BR> <BR> - (E)-2- {2- [3, 5-dichloro-4- (5-trifluoromethylpyrid-2- yloxy) phenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 93); <BR> <BR> - methyl (E)-2- {2- [3, 5-dichloro-4- (2-propynyloxy)- phe- noxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 94); methyl (E)-2- {2- [3, 5-dichloro-4- (2-propynyloxy) pheno- xymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 95);

- (E)-2- {2- [3, 5-dichloro-4- (2-propynyloxy)-phenoxy- methyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 96); - methyl (E)-2- (2- [3, 5-dichloro-4- (3-butyn-2-yloxy)- phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 97); - methyl (E)-2- {2- [3, 5-dichloro-4- (3-butyn-2-yloxy)- phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 98); - (E)-2- {2- [3, 5-dichloro-4- (3-butyn-2-yloxy) phenoxy- methyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 99); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate, thick oil; 1H-NMR (CDC13) : 8 3.74 (3H, s), 3.82 (3H, s), 4.60 (2H, d), 4.93 (2H, s), 6.30 (lH, t), 6.84 (2H, s), 7.10-7. 55 (4H, m), 7.62 (lH, s). (compound Nr. 100); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 101); - (E)-2- {2- [3, 5-dichloro-4- (3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl} N-methyl-2-methoxyimino- acetamide (compound Nr. 102); - methyl (E)-2- {2- [3, 5-dichloro-4- (cyanomethoxy) pheno- xymethyl] phenyl}-3-methoxyacrylate (compound Nr. 103);

methyl (E)-2- {2- [3, 5-dichloro-4- (cyanomethoxy) pheno- xymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 104); (E)-2- {2- [3, 5-dichloro-4- (cyanomethoxy) phenoxy- methyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 105) ; -methyl (E)-2-{2-[2, 6-dichloro-4-(2, 2-dimethylethyl) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 106); -methyl (E)-2-{2-[2, 6-dichloro-4-(2, 2-dimethylethyl) phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 107); - (E)-2-{2-[2, 6-dichloro-4-(2, 2-dimethylethyl) phenoxy- methyl] phenyl}-N-methyl-2-methoxyiminoacetamide (compound Nr. 108); <BR> <BR> - methyl (E)-2- [2- (3-cyclopropylmethoxy-4, 6-dichloro- phenoxymethyl) phenyl]-3-methoxyacrylate (compound Nr. 109); - methyl (E)-2- [2- (3-cyclopropylmethoxy-4, 6-dichloro- <BR> <BR> phenoxymethyl) phenyl] -2-methoxyiminoacetate (compound Nr. 110); (E)-2- [2- (3-cyclopropylmethoxy-4, 6-dichlorophenoxy- methyl) phenyl]-N-methyl-2-methoxyiminoacetamide (compound Nr. 111) ; methyl (E)-2- {2- [4- (2, 2-dichlorocyclopropyl) methoxy- 3, 5-dichlorophenoxymethyl] phenyl}-3-methoxyacrylate (com- pound Nr. 112); - methyl (E)-2- {2- [4- (2, 2-dichlorocyclopropyl) methoxy-

3, 5-dichlorophenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 113); - (E)-2- {2- [4- (2, 2-dichlorocyclopropyl) methoxy-3,5- dichlorophenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 114); - methyl (E)-2- {2- [3, 5-dichloro-4- (3-chloro-4, 4,4- trifluorobut-2-enyloxy) phenoxymethyl] phenyl}-3-methOxy- acrylate, thick oil, H-NMR (CDC13) : 8 3.74 (3H, s), 3.82 (3H, s), 4.72 (2H, m), 4.93 (2H, s), 6.72 (lH, m), 6.84 (2H, s), 7.10-7. 55 (4H, m), 7.62 (lH, s). (compound Nr. 115); - methyl (E)-2- {2- [3, 5-dichloro-4- (3-chloro-4, 4,4- trifluorobut-2-enyloxy) phenoxymethyl] phenyl}-2-methoxy- iminoacetate (compound Nr. 116); - (E)-2- {2- [3, 5-dichloro-4- (3-chloro-4, 4,4-trifluoro- but-2-enyloxy) phenoxymethyl] phenyl}-N-methyl-2-methoxy- iminoacetamide (compound Nr. 117); - methyl (E)-2- {2- [3, 5-dichloro-4- (3-bromo-4, 4,4- trifluorobut-2-enyloxy) phenoxymethyl] phenyl}-3-methoxy- acrylate (compound Nr. 118); - methyl (E)-2- {2- [3, 5-dichloro-4- (3-bromo-4, 4,4- trifluorobut-2-enyloxy) phenoxymethyl] phenyl}-2-methOxy- iminoacetate (compound Nr. 119); - (E)-2- {2- [3, 5-dichloro-4- (3-bromo-4, 4,4-trifluoro- but-2-enyloxy) phenoxymethyl] phenyl}-N-methyl-2-methoxy-

iminoacetamide (compound Nr. 120); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 4,4, 4-tetrafluoro- but-2-enyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 121); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 4,4, 4-tetrafluoro- but-2-enyloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 122); - (E)-2- {2- [3, 5-dichloro-4- (3, 4,4, 4-tetrafluoro-but-2- enyloxy) phenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 123); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dibromoprop-2- enyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 124); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dibromoprop-2- enyloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 125); - (E)-2- {2- [3, 5-dichloro-4- (3, 3-dibromoprop-2-enyloxy) phenoxymethyl] phenyl}-N-2-methoxyiminoacetamide (compound Nr. 126); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-difluoroprop-2- enyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 127); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-difluoroprop-2- enyloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 128);

- (E)-2- {2- [3, 5-dichloro-4- (3, 3-difluoroprop-2- enyloxy) phenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 129); - methyl (E)-2- {2- [5- (2, 2-dichlorocyclopropyl) methoxy- 2, 4-dichlorophenoxymethyl] phenyl}-3-methoxyacrylate (com- pound Nr. 130); - methyl (E)-2-2- [5- (2, 2-dichlorocyclopropyl) methoxy- 2, 4-dichlorophenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 131); - (E)-2-f2- [5- (2, 2-dichlorocyclopropyl) methoxy-2,4- dichlorophenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 132); - methyl (E)-2- {2- [4- (2, 2-dichlorocyclopropyl) methoxy- 2, 6-dichlorophenoxymethyl] phenyl}-3-methoxyacrylate (com- pound Nr. 133) ; - methyl (E)-2- {2- [4- (2, 2-dichlorocyclopropyl) methoxy- 2, 6-dichlorophenoxymethyl] phenyl}-2-methoxyiminoacetate (compound Nr. 134); (E)-2- (2- [4- (2, 2-dichlorocyclopropyl) methoxy-2,6- dichlorophenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 135); - methyl (E)-2- {2- [ (2, 4-dichloro-5- (3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate (compound Nr. 136); -methyl (E)-2-{2-[(2, 4-dichloro-5-(3, 3-dichloroprop-2-

enyloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 137); - (E)-2-{2-[(2, 4-dichloro-5-(3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl}-N-methyl-2-methOxyimino- acetamide (compound Nr. 138); - methyl (E)-2- {2- [ (2, 6-dichloro-4- (3, 3-dichloroprop-2- enyloxy) phenoxymethyl phenyl}-3-methoxyacrylate (compound Nr. 139); methyl (E)-2- {2- [ (2, 6-dichloro-4- (3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate (com- pound Nr. 140); - (E)-2-{2-[(2, 6-dichloro-4-(3, 3-dichloroprop-2- enyloxy) phenoxymethyl] phenyl}-N-methyl-2-methoxyimino- acetamide (compound Nr. 141); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dimethylbutoxy) phenoxymethyl] phenyl}-3-methoxyacrylate, m. p. 80°C, 1H-NMR (CDC13) : S 1. 0 (9H, s), 1.8 (2H, m), 3.73 (3H, s), 3.82 (3H, s), 3.98 (2H, t), 4.93 (2H, s), 6.84 (2H, s), 7.1- 7.55 (4H, m), 7.62 (lH, s); (compound Nr. 142); - methyl (E)-2- {2- [3, 5-dichloro-4- (3, 3-dimethylbutoxy) phenoxymethyl] phenyl}-2-methoxyiminoacetate, thick oil, (compound Nr. 143); - (E)-2- {2- [3, 5-dichloro-4- (3, 3-dimethylbutoxy) phe- noxymethyl] phenyl}-N-methyl-2-methoxyiminoacetamide, (compound Nr. 144);

- methyl (E)-2- (2- [3, 5-dichloro-4- (2, 4- dichlorobenzyloxy) phenoxymethyl] phenyl}-3-methoxyacrylate thick oil, (compound Nr. 145); methyl (E)-2- {2- [3, 5-dichloro-4- (4-chlorobenzyloxy)- phenoxymethyl] phenyl}-3-methoxyacrylate, solid with m. p.

112°C, (compound Nr. 146).

EXAMPLE 5 Determination of the acaricidal activity. a) Activity against adults of Tetranychus urticae.

Samples of bean leaves are infested with adult fe- male mites and sprayed, by means of a Potter Tower, with a hydro-acetone solution at 20% by volume of acetone, containing the product being tested at the desired con- centration and Tween 20 (0. 05%).

The mortality percentage is determined 48 hours af- ter treatment, compared with that of adult mites, by in- festing samples only treated with a hydro-acetone solu- tion at 20% by volume of acetone (blank).

The compounds tested provided a full activity at a dose of 500 ppm. b) Activity against eggs and larvae of Tetranychus urticae.

Samples of bean leaves, on which mite eggs were de- posited 24 hours before, were sprayed by means of a Pot- ter Tower with a hydro-acetone solution at 20% by volume

of acetone, containing the product being tested at the desired concentration and Tween 20 (0. 05%).

The percentage of unopened eggs is determined seven days after treatment, compared with that of eggs only treated with a hydro-acetone solution at 20% by volume of acetone (blank).

72 hours after examining the eggs, the mortality percentage of the larvae deriving from the treated eggs is evaluated and compared with that of the larvae deriv- ing from the blank eggs.

The compounds tested provided a full activity at a dose of 200 ppm.